Avelumab vs Chemotherapy for First-line Treatment of Advanced PD-L1+NSCLC: Primary Analysis from JAVELIN Lung 100
Tarih
2022Yazar
Reck, M.
Barlesi, F.
Yang, , J. C.-H.
Westeel, V.
Felip, E.
Ozguroglu, M.
Dols, M. Cobo
Sullivan, R.
Kowalski, D.
Andric, Z.
Lee, D. H.
Sezer, A.
Shamrai, V.
Szalai, Z.
Wang, X.
Xiong, H.
Jacob, N.
Mehr, K. Tadjalli
Park, K.